市場調査レポート
商品コード
1116534

メサラジンの世界市場:2022年

Global Mesalazine Market Research Report 2022

出版日: | 発行: QYResearch | ページ情報: 英文 118 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
メサラジンの世界市場:2022年
出版日: 2022年08月18日
発行: QYResearch
ページ情報: 英文 118 Pages
納期: 2~3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

COVID-19の大流行により、世界のメサラジンの市場規模は、2022年に1億7,973万米ドルと推定され、2028年までに2億2,348万米ドルに再調整され、予測期間(2022年~2028年)にCAGRで3.70%の成長が予測されています。

この健康危機による経済変化を十分に考慮すると、2021年にメサラジンの世界市場の53.03%を占める純度99%以上は、2028年までに1億3,798万米ドルに達し、2022年から2028年までのCAGRで6.02%の成長が予測されています。一方、錠剤セグメントは、この予測期間を通してCAGRで2.49%の成長に変更されています。

北米のメサラジン市場規模は2021年に1,867万米ドル、欧州は6,891万米ドルでした。北米の割合は2021年に11.54%、欧州の割合は42.59%で、欧州の市場シェアは2028年に40.76%に達し、分析期間を通じてCAGRで3.16%の成長が予測されています。アジアでは、日本と韓国が注目すべき市場であり、今後6年間のCAGRはそれぞれ2.64%と2.85%となっています。

世界のメサラジンの主要メーカーは、PharmaZell、Syntese A/S、Cambrex Corporation、Divis Laboratories、Chemi SpA、Ipca Laboratories、Hangzhou Brother、Lianyungang Fengheng Biopharm、Lasa Loboratoryなどです。収益面では、2021年のメサラジンの市場シェアは、世界3大企業が50.43%を占めています。

目次

第1章 メサラジン市場概要

  • メサラジンの製品概要と範囲
  • メサラジンのセグメント:タイプ別
    • 世界のメサラジンの販売成長率の比較:タイプ別(2022年~2028年)
    • 純度97%以上
    • 純度98%以上
    • 純度99%以上
  • メサラジンのセグメント:用途別
    • 世界のメサラジンの販売比較:用途別(2022年~2028年)
    • 錠剤
    • カプセル
    • ペレット・顆粒
    • 座薬
    • 浣腸
  • 世界のメサラジンの市場規模の推定と予測

第2章 メサラジン市場競合:メーカー別

  • 世界のメサラジンの販売の市場シェア:メーカー別(2017年~2022年)
  • 世界のメサラジンの収益の市場シェア:メーカー別(2017年~2022年)
  • 世界のメサラジンの平均価格:メーカー別(2017年~2022年)
  • メサラジンメーカーの製造拠点、提供エリア、製品タイプ
  • メサラジン市場の競合状況と動向
  • メーカーのM&A、拡張計画

第3章 メサラジンの遡及的市場シナリオ:地域別

  • 世界のメサラジンの遡及的市場シナリオ - 販売:地域別(2017年~2022年)
  • 世界のメサラジンの遡及的市場シナリオ - 収益:地域別(2017年~2022年)
  • 北米のメサラジンの市場ファクト・数値:国別
  • 欧州のメサラジンの市場ファクト・数値:国別
  • アジア太平洋地域のメサラジンの市場ファクト・数値:地域別
  • 南米のメサラジンの市場ファクト・数値:国別
  • 中東・アフリカのメサラジンの市場ファクト・数値:国別

第4章 メサラジンの過去の市場分析:タイプ別

  • 世界のメサラジンの販売の市場シェア:タイプ別(2017年~2022年)
  • 世界のメサラジンの収益の市場シェア:タイプ別(2017年~2022年)
  • 世界のメサラジンの価格:タイプ別(2017年~2022年)

第5章 メサラジンの過去の市場分析:用途別

  • 世界のメサラジンの販売の市場シェア:用途別(2017年~2022年)
  • 世界のメサラジンの収益の市場シェア:用途別(2017年~2022年)
  • 世界のメサラジンの価格:用途別(2017年~2022年)

第6章 主要企業プロファイル

  • PharmaZell
  • Syntese A/S
  • Cambrex Corporation
  • Divis Laboratories
  • Chemi SpA
  • Ipca Laboratories
  • Hangzhou Brother
  • Lianyungang Fengheng Biopharm
  • Lasa Loboratory
  • Corden Pharma Bergamo
  • Erregierre SpA
  • CTX Lifescience
  • Ishita Active Pharma Ingredients
  • YC Biotech (Jiangsu)
  • Xinxiang Tianfeng Fine Chemical

第7章 メサラジンの製造コスト分析

  • メサラジンの主要原材料分析
  • メサラジンの製造プロセス分析
  • メサラジンの業界チェーン分析

第8章 マーケティングチャネル・ディストリビューター・顧客

  • マーケティングチャネル
  • メサラジンのディストリビューターリスト
  • メサラジンの顧客

第9章 メサラジンの市場力学

  • メサラジンの業界動向
  • メサラジンの市場促進要因
  • メサラジンの市場課題

第10章 世界の市場予測

  • メサラジン市場の推定と予測:タイプ別
  • メサラジン市場の推定と予測:用途別
  • メサラジン市場の推定と予測:地域別

第11章 調査結果・結論

第12章 調査手法・データソース

図表

LIST OF TABLES

  • Table 1. Global Mesalazine Sales Growth Rate Comparison by Type (2022-2028) & (Tons) & (US$ Million)
  • Table 2. Major Manufacturers of Purity ≥97%
  • Table 3. Major Manufacturers of Purity ≥98%
  • Table 4. Major Manufacturers of Purity ≥99%
  • Table 5. Global Mesalazine Sales Growth Rate Comparison by Application (2022-2028) & (Tons) & (US$ Million)
  • Table 6. Global Mesalazine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 7. Global Mesalazine Market Competitive Situation by Manufacturers in 2021
  • Table 8. Global Mesalazine Sales (Tons) of Key Manufacturers (2017-2022)
  • Table 9. Global Mesalazine Sales Market Share by Manufacturers (2017-2022)
  • Table 10. Global Mesalazine Revenue (US$ Million) by Manufacturers (2017-2022)
  • Table 11. Global Mesalazine Revenue Share by Manufacturers (2017-2022)
  • Table 12. Global Market Mesalazine Average Price (US$/Kg) of Key Manufacturers (2017-2022)
  • Table 13. Manufacturers Mesalazine Manufacturing Sites and Area Served
  • Table 14. Manufacturers Mesalazine Product Type
  • Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 16. Global Mesalazine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalazine as of 2021)
  • Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
  • Table 18. Global Mesalazine Sales by Region (2017-2022) & (Tons)
  • Table 19. Global Mesalazine Sales Market Share by Region (2017-2022)
  • Table 20. Global Mesalazine Revenue by Region (2017-2022) & (US$ Million)
  • Table 21. Global Mesalazine Revenue Market Share by Region (2017-2022)
  • Table 22. North America Mesalazine Sales by Country (2017-2022) & (Tons)
  • Table 23. North America Mesalazine Sales Market Share by Country (2017-2022)
  • Table 24. North America Mesalazine Revenue by Country (2017-2022) & (US$ Million)
  • Table 25. North America Mesalazine Revenue Market Share by Country (2017-2022)
  • Table 26. Europe Mesalazine Sales by Country (2017-2022) & (Tons)
  • Table 27. Europe Mesalazine Sales Market Share by Country (2017-2022)
  • Table 28. Europe Mesalazine Revenue by Country (2017-2022) & (US$ Million)
  • Table 29. Europe Mesalazine Revenue Market Share by Country (2017-2022)
  • Table 30. Asia Pacific Mesalazine Sales by Region (2017-2022) & (Tons)
  • Table 31. Asia Pacific Mesalazine Sales Market Share by Region (2017-2022)
  • Table 32. Asia Pacific Mesalazine Revenue by Region (2017-2022) & (US$ Million)
  • Table 33. Asia Pacific Mesalazine Revenue Market Share by Region (2017-2022)
  • Table 34. South America Mesalazine Sales by Country (2017-2022) & (Tons)
  • Table 35. South America Mesalazine Sales Market Share by Country (2017-2022)
  • Table 36. South America Mesalazine Revenue by Country (2017-2022) & (US$ Million)
  • Table 37. South America Mesalazine Revenue Market Share by Country (2017-2022)
  • Table 38. Middle East and Africa Mesalazine Sales by Country (2017-2022) & (Tons)
  • Table 39. Middle East and Africa Mesalazine Sales Market Share by Country (2017-2022)
  • Table 40. Middle East and Africa Mesalazine Revenue by Country (2017-2022) & (US$ Million)
  • Table 41. Middle East and Africa Mesalazine Revenue Market Share by Country (2017-2022)
  • Table 42. Global Mesalazine Sales by Type (2017-2022) & (Tons)
  • Table 43. Global Mesalazine Sales Market Share by Type (2017-2022)
  • Table 44. Global Mesalazine Revenue by Type (2017-2022) & (US$ Million)
  • Table 45. Global Mesalazine Revenue Share by Type (2017-2022)
  • Table 46. Global Mesalazine Price by Type (2017-2022) & (US$/Kg)
  • Table 47. Global Mesalazine Sales (Tons) by Application (2017-2022)
  • Table 48. Global Mesalazine Sales Market Share by Application (2017-2022)
  • Table 49. Global Mesalazine Revenue by Application (2017-2022) & (US$ Million)
  • Table 50. Global Mesalazine Revenue Share by Application (2017-2022)
  • Table 51. Global Mesalazine Price by Application (2017-2022) & (US$/Kg)
  • Table 52. PharmaZell Corporation Information
  • Table 53. PharmaZell Description and Business Overview
  • Table 54. PharmaZell Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 55. PharmaZell Mesalazine Product
  • Table 56. Syntese A/S Corporation Information
  • Table 57. Syntese A/S Description and Business Overview
  • Table 58. Syntese A/S Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 59. Syntese A/S Mesalazine Product
  • Table 60. Cambrex Corporation Corporation Information
  • Table 61. Cambrex Corporation Description and Business Overview
  • Table 62. Cambrex Corporation Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 63. Cambrex Corporation Mesalazine Product
  • Table 64. Divis Laboratories Corporation Information
  • Table 65. Divis Laboratories Description and Business Overview
  • Table 66. Divis Laboratories Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 67. Divis Laboratories Mesalazine Product
  • Table 68. Chemi SpA Corporation Information
  • Table 69. Chemi SpA Description and Business Overview
  • Table 70. Chemi SpA Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 71. Chemi SpA Mesalazine Product
  • Table 72. Ipca Laboratories Corporation Information
  • Table 73. Ipca Laboratories Description and Business Overview
  • Table 74. Ipca Laboratories Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 75. Ipca Laboratories Mesalazine Product
  • Table 76. Hangzhou Brother Corporation Information
  • Table 77. Hangzhou Brother Description and Business Overview
  • Table 78. Hangzhou Brother Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 79. Hangzhou Brother Mesalazine Product
  • Table 80. Lianyungang Fengheng Biopharm Corporation Information
  • Table 81. Lianyungang Fengheng Biopharm Description and Business Overview
  • Table 82. Lianyungang Fengheng Biopharm Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 83. Lianyungang Fengheng Biopharm Mesalazine Product
  • Table 84. Lasa Loboratory Corporation Information
  • Table 85. Lasa Loboratory Description and Business Overview
  • Table 86. Lasa Loboratory Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 87. Lasa Loboratory Mesalazine Product
  • Table 88. Corden Pharma Bergamo Corporation Information
  • Table 89. Corden Pharma Bergamo Description and Business Overview
  • Table 90. Corden Pharma Bergamo Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 91. Corden Pharma Bergamo Mesalazine Product
  • Table 92. Erregierre SpA Corporation Information
  • Table 93. Erregierre SpA Description and Business Overview
  • Table 94. Erregierre SpA Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 95. Erregierre SpA Mesalazine Product
  • Table 96. CTX Lifescience Corporation Information
  • Table 97. CTX Lifescience Description and Business Overview
  • Table 98. CTX Lifescience Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 99. CTX Lifescience Mesalazine Product
  • Table 100. Ishita Active Pharma Ingredients Corporation Information
  • Table 101. Ishita Active Pharma Ingredients Description and Business Overview
  • Table 102. Ishita Active Pharma Ingredients Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 103. Ishita Active Pharma Ingredients Mesalazine Product
  • Table 104. YC Biotech (Jiangsu) Corporation Information
  • Table 105. YC Biotech (Jiangsu) Description and Business Overview
  • Table 106. YC Biotech (Jiangsu) Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 107. YC Biotech (Jiangsu) Mesalazine Product
  • Table 108. Xinxiang Tianfeng Fine Chemical Corporation Information
  • Table 109. Xinxiang Tianfeng Fine Chemical Description and Business Overview
  • Table 110. Xinxiang Tianfeng Fine Chemical Mesalazine Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
  • Table 111. Xinxiang Tianfeng Fine Chemical Mesalazine Product
  • Table 112. Production Base and Market Concentration Rate of Raw Material
  • Table 113. Key Suppliers of Raw Materials
  • Table 114. Mesalazine Distributors List
  • Table 115. Mesalazine Customers List
  • Table 116. Mesalazine Market Trends
  • Table 117. Mesalazine Market Opportunities
  • Table 118. Mesalazine Market Drivers
  • Table 119. Mesalazine Market Challenges
  • Table 120. Global Mesalazine Sales Forecast by Type (2023-2028) & (Tons)
  • Table 121. Global Mesalazine Sales Market Share Forecast by Type (2023-2028)
  • Table 122. Global Mesalazine Revenue Forecast by Type (2023-2028) & (US$ Million)
  • Table 123. Global Mesalazine Revenue Market Share Forecast by Type (2023-2028)
  • Table 124. Global Mesalazine Sales Forecast by Application (2023-2028) & (Tons)
  • Table 125. Global Mesalazine Sales Market Share Forecast by Application (2023-2028)
  • Table 126. Global Mesalazine Revenue Forecast by Application (2023-2028) & (US$ Million)
  • Table 127. Global Mesalazine Revenue Market Share Forecast by Application (2023-2028)
  • Table 128. Global Mesalazine Sales Forecast by Region (2023-2028) & (Tons)
  • Table 129. Global Mesalazine Sales Market Share Forecast by Region (2023-2028)
  • Table 130. Global Mesalazine Revenue Forecast by Region (2023-2028) & (US$ Million)
  • Table 131. Global Mesalazine Revenue Market Share Forecast by Region (2023-2028)
  • Table 132. Research Programs/Design for This Report
  • Table 133. Key Data Information from Secondary Sources
  • Table 134. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Product Picture of Mesalazine
  • Figure 2. Global Mesalazine Market Share by Type: 2022 & 2028
  • Figure 3. Global Mesalazine Market Share by Application: 2022 & 2028
  • Figure 4. Tablets
  • Figure 5. Capsules
  • Figure 6. Pellet and Granule
  • Figure 7. Suppository
  • Figure 8. Enema
  • Figure 9. Global Mesalazine Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 10. Global Mesalazine Market Size (2017-2028) & (US$ Million)
  • Figure 11. Global Mesalazine Sales (2017-2028) & (Tons)
  • Figure 12. Global Mesalazine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Figure 13. Mesalazine Sales Share by Manufacturers in 2021
  • Figure 14. Global Mesalazine Revenue Share by Manufacturers in 2021
  • Figure 15. Global 5 Largest Mesalazine Players: Market Share by Revenue in Mesalazine in 2021
  • Figure 16. Global 10 Largest Mesalazine Players: Market Share by Revenue in Mesalazine in 2021
  • Figure 17. Mesalazine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
  • Figure 18. North America Mesalazine Sales Market Share by Country in 2021
  • Figure 19. United States Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 20. Canada Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 21. Mexico Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 22. Europe Mesalazine Sales Market Share by Country in 2021
  • Figure 23. Germany Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 24. France Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 25. U.K. Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 26. Italy Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 27. Russia Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 28. Asia Pacific Mesalazine Sales Market Share by Country in 2021
  • Figure 29. China Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 30. Japan Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 31. South Korea Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 32. India Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 33. Australia Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 34. SEA Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 35. South America Mesalazine Sales Market Share by Country in 2021
  • Figure 36. Brazil Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 37. Argentina Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 38. Middle East and Africa Mesalazine Sales Market Share by Country in 2021
  • Figure 39. GCC Countries Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 40. Israel Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 41. Iran Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 42. South Africa Mesalazine Revenue Growth Rate (2017-2022) & (US$ Million)
  • Figure 43. Sales Market Share of Mesalazine by Type (2017-2022)
  • Figure 44. Sales Market Share of Mesalazine by Application (2017-2022)
  • Figure 45. Manufacturing Process Analysis of Mesalazine
  • Figure 46. Mesalazine Industrial Chain Analysis
  • Figure 47. Channels of Distribution
  • Figure 48. Distributors Profiles
  • Figure 49. Bottom-up and Top-down Approaches for This Report
  • Figure 50. Data Triangulation
  • Figure 51. Key Executives Interviewed 98
目次

Due to the COVID-19 pandemic, the global Mesalazine market size is estimated to be worth US$ 179.73 million in 2022 and is forecast to a readjusted size of US$ 223.48 million by 2028 with a CAGR of 3.70% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity ≥99% accounting for 53.03% of the Mesalazine global market in 2021, is projected to value US$ 137.98 million by 2028, growing at a revised 6.02% CAGR from 2022 to 2028. While Tablets segment is altered to an 2.49% CAGR throughout this forecast period.

North America Mesalazine market size was US$ 18.67 million in 2021, while Europe was US$ 68.91 million. The proportion of the North America was 11.54% in 2021, while Europe's percentage was 42.59%, and it is predicted that Europe market share will reach 40.76% in 2028, trailing a CAGR of 3.16% through the analysis period. As for the Asia, the notable markets are Japan and South Korea, CAGR is 2.64% and 2.85% respectively for the next 6-year period.

The global major manufacturers of Mesalazine include PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm, and Lasa Loboratory, etc. In terms of revenue, the global three largest players hold a 50.43% market share of Mesalazine in 2021.

This report focuses on Mesalazine volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Mesalazine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan, etc.

Segment Analysis:

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment Analysis:

The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2017 to 2028. by Application segment also provides consumption during the forecast period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

By Company

  • PharmaZell
  • Syntese A/S
  • Cambrex Corporation
  • Divis Laboratories
  • Chemi SpA
  • Ipca Laboratories
  • Hangzhou Brother
  • Lianyungang Fengheng Biopharm
  • Lasa Loboratory
  • Corden Pharma Bergamo
  • Erregierre SpA
  • CTX Lifescience
  • Ishita Active Pharma Ingredients
  • YC Biotech (Jiangsu)
  • Xinxiang Tianfeng Fine Chemical

Segment by Type

  • Purity ≥97%
  • Purity ≥98%
  • Purity ≥99%

Segment by Application

  • Tablets
  • Capsules
  • Pellet and Granule
  • Suppository
  • Enema
  • Others

Consumption by Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Southeast Asia
    • Others
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Others
  • South America
    • Brazil
    • Argentina
    • Others
  • Middle East and Africa
    • GCC Countries
    • Israel
    • Iran
    • South Africa
    • Others

TABLE OF CONTENTS

1 Mesalazine Market Overview

  • 1.1 Product Overview and Scope of Mesalazine
  • 1.2 Mesalazine Segment by Type
    • 1.2.1 Global Mesalazine Sales Growth Rate Comparison by Type (2022-2028)
    • 1.2.2 Purity ≥97%
    • 1.2.3 Purity ≥98%
    • 1.2.4 Purity ≥99%
  • 1.3 Mesalazine Segment by Application
    • 1.3.1 Global Mesalazine Sales Comparison by Application (2022-2028)
    • 1.3.2 Tablets
    • 1.3.3 Capsules
    • 1.3.4 Pellet and Granule
    • 1.3.5 Suppository
    • 1.3.6 Enema
  • 1.4 Global Mesalazine Market Size Estimates and Forecasts
    • 1.4.1 Global Mesalazine Revenue 2017-2028
    • 1.4.2 Global Mesalazine Sales 2017-2028
    • 1.4.3 Mesalazine Market Size by Region: 2017 Versus 2021 Versus 2028

2 Mesalazine Market Competition by Manufacturers

  • 2.1 Global Mesalazine Sales Market Share by Manufacturers (2017-2022)
  • 2.2 Global Mesalazine Revenue Market Share by Manufacturers (2017-2022)
  • 2.3 Global Mesalazine Average Price by Manufacturers (2017-2022)
  • 2.4 Manufacturers Mesalazine Manufacturing Sites, Area Served, Product Type
  • 2.5 Mesalazine Market Competitive Situation and Trends
    • 2.5.1 Mesalazine Market Concentration Rate
    • 2.5.2 The Global 5 and 10 Largest Mesalazine Players Market Share by Revenue
    • 2.5.3 Global Mesalazine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Mesalazine Retrospective Market Scenario by Region

  • 3.1 Global Mesalazine Retrospective Market Scenario in Sales by Region: 2017-2022
  • 3.2 Global Mesalazine Retrospective Market Scenario in Revenue by Region: 2017-2022
  • 3.3 North America Mesalazine Market Facts & Figures by Country
    • 3.3.1 North America Mesalazine Sales by Country
    • 3.3.2 North America Mesalazine Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
    • 3.3.5 Mexico
  • 3.4 Europe Mesalazine Market Facts & Figures by Country
    • 3.4.1 Europe Mesalazine Sales by Country
    • 3.4.2 Europe Mesalazine Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Mesalazine Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Mesalazine Sales by Region
    • 3.5.2 Asia Pacific Mesalazine Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 SEA
  • 3.6 South America Mesalazine Market Facts & Figures by Country
    • 3.6.1 South America Mesalazine Sales by Country
    • 3.6.2 South America Mesalazine Revenue by Country
    • 3.6.3 Brazil
    • 3.6.4 Argentina
  • 3.7 Middle East and Africa Mesalazine Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Mesalazine Sales by Country
    • 3.7.2 Middle East and Africa Mesalazine Revenue by Country
    • 3.7.3 GCC Countries
    • 3.7.4 Israel
    • 3.7.5 Iran
    • 3.7.6 South Africa

4 Mesalazine Historic Market Analysis by Type

  • 4.1 Global Mesalazine Sales Market Share by Type (2017-2022)
  • 4.2 Global Mesalazine Revenue Market Share by Type (2017-2022)
  • 4.3 Global Mesalazine Price by Type (2017-2022)

5 Mesalazine Historic Market Analysis by Application

  • 5.1 Global Mesalazine Sales Market Share by Application (2017-2022)
  • 5.2 Global Mesalazine Revenue Market Share by Application (2017-2022)
  • 5.3 Global Mesalazine Price by Application (2017-2022)

6 Key Companies Profiled

  • 6.1 PharmaZell
    • 6.1.1 PharmaZell Corporation Information
    • 6.1.2 PharmaZell Description and Business Overview
    • 6.1.3 PharmaZell Mesalazine Sales, Revenue and Gross Margin (2017-2022)
    • 6.1.4 PharmaZell Mesalazine Product Portfolio
  • 6.2 Syntese A/S
    • 6.2.1 Syntese A/S Corporation Information
    • 6.2.2 Syntese A/S Description and Business Overview
    • 6.2.3 Syntese A/S Mesalazine Sales, Revenue and Gross Margin (2017-2022)
    • 6.2.4 Syntese A/S Mesalazine Product Portfolio
  • 6.3 Cambrex Corporation
    • 6.3.1 Cambrex Corporation Corporation Information
    • 6.3.2 Cambrex Corporation Description and Business Overview
    • 6.3.3 Cambrex Corporation Mesalazine Sales, Revenue and Gross Margin (2017-2022)
    • 6.3.4 Cambrex Corporation Mesalazine Product Portfolio
  • 6.4 Divis Laboratories
    • 6.4.1 Divis Laboratories Corporation Information
    • 6.4.2 Divis Laboratories Description and Business Overview
    • 6.4.3 Divis Laboratories Mesalazine Sales, Revenue and Gross Margin (2017-2022)
    • 6.4.4 Divis Laboratories Mesalazine Product Portfolio
  • 6.5 Chemi SpA
    • 6.5.1 Chemi SpA Corporation Information
    • 6.5.2 Chemi SpA Description and Business Overview
    • 6.5.3 Chemi SpA Mesalazine Sales, Revenue and Gross Margin (2017-2022)
    • 6.5.4 Chemi SpA Mesalazine Product Portfolio
  • 6.6 Ipca Laboratories
    • 6.6.1 Ipca Laboratories Corporation Information
    • 6.6.2 Ipca Laboratories Description and Business Overview
    • 6.6.3 Ipca Laboratories Mesalazine Sales, Revenue and Gross Margin (2017-2022)
    • 6.6.4 Ipca Laboratories Mesalazine Product Portfolio
  • 6.7 Hangzhou Brother
    • 6.7.1 Hangzhou Brother Corporation Information
    • 6.7.2 Hangzhou Brother Description and Business Overview
    • 6.7.3 Hangzhou Brother Mesalazine Sales, Revenue and Gross Margin (2017-2022)
    • 6.7.4 Hangzhou Brother Mesalazine Product Portfolio
  • 6.8 Lianyungang Fengheng Biopharm
    • 6.8.1 Lianyungang Fengheng Biopharm Corporation Information
    • 6.8.2 Lianyungang Fengheng Biopharm Description and Business Overview
    • 6.8.3 Lianyungang Fengheng Biopharm Mesalazine Sales, Revenue and Gross Margin (2017-2022)
    • 6.8.4 Lianyungang Fengheng Biopharm Mesalazine Product Portfolio
  • 6.9 Lasa Loboratory
    • 6.9.1 Lasa Loboratory Corporation Information
    • 6.9.2 Lasa Loboratory Description and Business Overview
    • 6.9.3 Lasa Loboratory Mesalazine Sales, Revenue and Gross Margin (2017-2022)
    • 6.9.4 Lasa Loboratory Mesalazine Product Portfolio
  • 6.10 Corden Pharma Bergamo
    • 6.10.1 Corden Pharma Bergamo Corporation Information
    • 6.10.2 Corden Pharma Bergamo Description and Business Overview
    • 6.10.3 Corden Pharma Bergamo Mesalazine Sales, Revenue and Gross Margin (2017-2022)
    • 6.10.4 Corden Pharma Bergamo Mesalazine Product Portfolio
  • 6.11 Erregierre SpA
    • 6.11.1 Erregierre SpA Corporation Information
    • 6.11.2 Erregierre SpA Description and Business Overview
    • 6.11.3 Erregierre SpA Mesalazine Sales, Revenue and Gross Margin (2017-2022)
    • 6.11.4 Erregierre SpA Mesalazine Product Portfolio
  • 6.12 CTX Lifescience
    • 6.12.1 CTX Lifescience Corporation Information
    • 6.12.2 CTX Lifescience Description and Business Overview
    • 6.12.3 CTX Lifescience Mesalazine Sales, Revenue and Gross Margin (2017-2022)
    • 6.12.4 CTX Lifescience Mesalazine Product Portfolio
  • 6.13 Ishita Active Pharma Ingredients
    • 6.13.1 Ishita Active Pharma Ingredients Corporation Information
    • 6.13.2 Ishita Active Pharma Ingredients Description and Business Overview
    • 6.13.3 Ishita Active Pharma Ingredients Mesalazine Sales, Revenue and Gross Margin (2017-2022)
    • 6.13.4 Ishita Active Pharma Ingredients Mesalazine Product Portfolio
  • 6.14 YC Biotech (Jiangsu)
    • 6.14.1 YC Biotech (Jiangsu) Corporation Information
    • 6.14.2 YC Biotech (Jiangsu) Description and Business Overview
    • 6.14.3 YC Biotech (Jiangsu) Mesalazine Sales, Revenue and Gross Margin (2017-2022)
    • 6.14.4 YC Biotech (Jiangsu) Mesalazine Product Portfolio
  • 6.15 Xinxiang Tianfeng Fine Chemical
    • 6.15.1 Xinxiang Tianfeng Fine Chemical Corporation Information
    • 6.15.2 Xinxiang Tianfeng Fine Chemical Description and Business Overview
    • 6.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine Sales, Revenue and Gross Margin (2017-2022)
    • 6.15.4 Xinxiang Tianfeng Fine Chemical Mesalazine Product Portfolio

7 Mesalazine Manufacturing Cost Analysis

  • 7.1 Mesalazine Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Manufacturing Process Analysis of Mesalazine
  • 7.3 Mesalazine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Mesalazine Distributors List
  • 8.3 Mesalazine Customers

9 Mesalazine Market Dynamics

  • 9.1 Mesalazine Industry Trends
  • 9.2 Mesalazine Market Drivers
  • 9.3 Mesalazine Market Challenges

10 Global Market Forecast

  • 10.1 Mesalazine Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Mesalazine by Type (2023-2028)
    • 10.1.2 Global Forecasted Revenue of Mesalazine by Type (2023-2028)
  • 10.2 Mesalazine Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Mesalazine by Application (2023-2028)
    • 10.2.2 Global Forecasted Revenue of Mesalazine by Application (2023-2028)
  • 10.3 Mesalazine Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Mesalazine by Region (2023-2028)
    • 10.3.2 Global Forecasted Revenue of Mesalazine by Region (2023-2028)

11 Research Findings and Conclusion

12 Methodology and Data Source

  • 12.1 Methodology/Research Approach
    • 12.1.1 Research Programs/Design
    • 12.1.2 Market Size Estimation
    • 12.1.3 Market Breakdown and Data Triangulation
  • 12.2 Data Source
    • 12.2.1 Secondary Sources
    • 12.2.2 Primary Sources
  • 12.3 Author List
  • 12.4 Disclaimer 99